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these cells. Importantly, Syap1 knockout does not affect 
motoneuron survival or axon growth. Unexpectedly, neither 
knockdown nor knockout of Syap1 in cultured motoneurons 
is associated with reduced Ser473 or Thr308 phosphorylation 
of Akt. Our findings demonstrate a widespread expression 
of Syap1 in the mouse central nervous system with region-
ally specific distribution patterns as illustrated in particular 
for olfactory bulb, hippocampus, and cerebellum.
Keywords Brain · BSTA · Viability · Syap1 localization · 
Glutamatergic synapses · PKB/Akt phosphorylation
Introduction
The synapse-associated protein of 47 kDa (Sap47) in Dros-
ophila represents the founding member of a family of syn-
apse-associated proteins with a BSD domain. Sap47 has 
originally been identified by a monoclonal antibody that 
binds to most neuropil regions of larval and adult brains 
(Reichmuth et al. 1995; Hofbauer et al. 2009). The super-
family of proteins containing a BSD domain includes 
functionally diverse proteins such as BTF2-like transcrip-
tion factors, Sap47 homologues, and DOS2-like proteins 
involved in ubiquitin metabolism and control of single-
copy DNA replication (Doerks et al. 2002). In glutamater-
gic larval motoneurons of Drosophila, the Sap47 protein 
is concentrated in presynaptic boutons in close proximity 
to synaptic vesicles. Basic synaptic transmission is nor-
mal in Sap47 null mutants, but current clamp recordings at 
larval neuromuscular junctions reveal enhanced synaptic 
depression during high-frequency stimulation, indicating 
a defect in short-term synaptic plasticity. At the behavioral 
level, Sap47 null mutant larvae show a ~50 % reduction in 
the ability to learn and/or remember the association of an 
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odorant with a rewarding tastant (Funk et al. 2004; Saum-
weber et al. 2011).
The mammalian homologue of Sap47 termed Syap1 is 
widely expressed as its mRNA is detected in most human 
tissues (Chang et al. 2001). It has been shown to be dif-
ferentially regulated by tamoxifen in breast cancer cells 
(Al-Dhaheri et al. 2006). Recently, Syap1/BSTA (BSD 
domain-containing signal transducer and Akt interactor) 
was shown to play an essential role in adipocyte differentia-
tion from embryonic stem cells by promoting phosphoryla-
tion of Akt1 at Ser473 after growth factor stimulation which 
results in suppressed expression of the gene for the FoxC2 
transcription factor. It was demonstrated that in divid-
ing cells, the BSD domain is essential for the interaction 
between Syap1 and Akt1 which in turn appears to depend 
on mTORC2-mediated Syap1/BSTA phosphorylation 
(Yao et al. 2013). These results raise the question whether 
Syap1/BSTA or Sap47 deficiencies could also modify Akt 
signaling in differentiated neurons, which could offer a 
molecular explanation for the observed plasticity defects 
in Sap47 mutants of Drosophila. In vertebrates, the three 
isoforms of serine/threonine kinase B (PKB/Akt) play 
important roles in nervous system-related functions such as 
neuronal differentiation, neurite growth, neuronal survival, 
and regulation of transcription and protein synthesis as well 
as neuronal maintenance and plasticity. Thus, a defect in 
Akt regulation caused by Syap1/Sap47 deficiency would 
certainly be compatible with altered synaptic plasticity and 
behavior as observed in Sap47 null mutant flies.
No information on Syap1 function in the mammalian 
nervous system is presently available. In both humans and 
mice, the Syap1 gene is located on the X-chromosome. 
In a mouse mutational screen of X-chromosomal genes, a 
gene-trap insertion leading to a hemizygous Syap1 mutant 
embryo at stage E9.5 showed no obvious morphological 
alterations and was therefore not further investigated (Cox 
et al. 2010). Here, we established a knock-out mouse line 
from an embryonic stem cell line with a targeted mutation 
of Syap1 and use knock-out animals of the first four gen-
erations as negative controls to provide an initial immuno-
chemical characterization of the distribution of Syap1 in 
brain tissue and cultured embryonic primary motoneurons. 
We observe that Syap1 knockout does not cause obvious 
morphological defects in young mice or gross structural 
changes in brain morphology. Immunoreactivity in wild-
type mouse brain sections detected with a polyclonal anti-
serum generated against human Syap1 indicates that the 
protein is widely expressed in virtually all brain areas with 
strong signals in perikarya of subpopulations of neurons 
and in neuropil regions particularly rich in glutamatergic 
synapses. After 7 days in culture, Syap1 knock-out moto-
neurons show normal axon length and survival rate. Neither 
knockdown nor knockout of Syap1 in cultured motoneurons 
was associated with altered activation of Akt. Our results 
indicate that organismal function of Syap1 appears to be 
more subtle than expected considering its requirement for 
adipocyte differentiation, and we have no evidence that its 
molecular function in cultured motoneurons involves the 
activation of the PI3K/Akt pathway.
Materials and methods
Animals and ethics statement
C57BL/6J and CD1 mice were kept at the animal facilities 
of the Institute of Clinical Neurobiology at the University 
Hospital of Würzburg providing controlled conditions such 
as ad libitum food and water supply, at 20–22 °C, 55–65 % 
humidity, and a 12/12-h light/dark cycle. Specific patho-
gen-free quality of the animals was frequently tested and 
confirmed according to FELASA recommendations. Each 
experiment was performed strictly following the regula-
tions on animal protection of the German federal law, the 
Association for Assessment and Accreditation of Labora-
tory Animal Care and of the University of Würzburg, in 
agreement with, under control of, and with the approval of 
the local veterinary authority and Committee on the Ethics 
of Animal Experiments, i.e., Regierung von Unterfranken 
and Veterinaeramt der Stadt Würzburg (License numbers 
566/200-244/13 and 55.2-2531.01-08/14). Parts of the pre-
sent study were discussed and approved by the institutional 
ethics committee of the University of Veterinary Medicine 
Vienna, and an animal experiment license was granted 
under BMWF-68.205/0023-II/3b/2014 (Austrian Federal 
Ministry of Science and Research).
Generation of Syap1 knock‑out mice
ES cell clone HEPD0680_2_C02 with a targeted Syap1 
locus was obtained from the “The European Conditional 
Mouse Mutagenesis Project” (EUCOMM, Munich). The 
targeted mutation was induced according to the general 
strategy of EUCOMM, resulting in a “knockout-first” lacZ-
reporter-tagged Syap1tm1a insertion allele with conditional 
potential. The insertion in intron 3 includes the mouse En2 
splice acceptor to generate a null allele through splicing to 
a lacZ trapping element with an SV40 polyadenylation sig-
nal (Skarnes et al. 2011).
After expansion of the clone according to the EUCOMM 
recommendations, 10–15 ES cells were injected into 
BALB/c host blastocysts. Injected embryos were cultured 
for 3–4 h to recover and then transferred into the right 
uterus horn of 2.5 dpc pseudopregnant CD1 surrogate moth-
ers. The offspring were selected based on their chimeric 
coat color. High-percentage male chimeras were bred with 
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C57BL/6N females, and the F1 offspring were genotyped 
by PCR for the neomycin transferase selection marker 
(Neo) and by Southern analysis. Due to the X-chromo-
somal location of Syap1, all mutants of the F1 generation 
were heterozygous females which were mated to C57BL/6J 
males. Mutants of the F2 generation were intercrossed in 
order to produce homozygous mutant females. Due to the 
engrailed-2 splice acceptor site (SA) and a coding region 
of the mouse engrailed-2 protein (En-2) upstream of lacZ, a 
bi-cistronic transcript is generated producing a fusion pro-
tein consisting of a short Syap1 fragment translated from 
exon-1 to exon-3 of Syap1 and an En-2 fragment (Fig. 1). 
The Syap1 fragment of this protein is predicted to be non-
functional as it lacks the conserved BSD domain (Doerks 
et al. 2002) which has been shown to be a requirement for 
Syap1 function (Yao et al. 2013). Therefore, unless there 
is residual splicing from exon-3 to exon-4, mice homo- 
or hemizygous for the Syap1tm1a allele will be Syap1 null 
mutants. Due to an IRES sequence upstream of lacZ, 
β-galactosidase is translated from the bi-cistronic mRNA 
and can provide information of Syap1 expression in wild-
type mice. The targeting construct Syap1tm1a also allows 
for reconstitution of gene function and the generation of a 
Syap1tm1c conditional knock-out allele following exposure 
to site-specific Flp recombination.
RNA isolation and quantitative real‑time PCR
RNA was isolated from adult mouse cortex with the TRI 
Reagent (Sigma-Aldrich) following the manufacturer`s 
instructions. Contamination by genomic DNA was reduced 
by a subsequent DNase treatment of the isolated RNA. 
500 ng–1 µg of total RNA was used for cDNA synthesis 
employing random primers and SuperScriptIII Reverse 
Transcriptase (Invitrogen). The cDNA was diluted 1:5 in 
Tris-HCl with pH 8.0 containing 10 % bovine serum albu-
min (BSA) and used for quantitative real-time PCR with 
the Luminaris HiGreen qPCR Master Mix (Thermo Scien-
tific) on a Lightcycler 1.5 (Roche) as previously described 
(Briese et al. 2016). Sequences of the primers are listed in 
Supplementary Table S1.
Antibodies
The polyclonal Syap1 antiserum generated against affin-
ity-purified human Syap1 was obtained from Proteintech, 
Chicago, IL, USA (rabbit, 16272-1-AP; Western Blot 
(WB): 1/3000, immunocytochemistry (IC): 1/200)). Anti-
bodies against α-tubulin (T5168; WB: 1/4000, IC: 1/2000) 
and acetylated α-tubulin (mouse, clone 6-11b-1; T7451; 
WB: 1/4000, IC: 1/2000) were obtained from Sigma. 
Tyrosinated α-tubulin antibody (rat, clone YL1/2; ab6160; 
WB: 1/2000), histone H3 antibody (rabbit, ab8580; WB 
1/30000), tyrosine hydroxylase (TH) antibody (chicken, 
ab76442; IC: 1/500), and GFP antibody (chicken, ab 
13970; IC: 1/2000) were supplied by Abcam, Cambridge, 
UK. Antibodies against Akt (rabbit, #9272; WB: 1/4000), 
Akt (mouse, #2966; IC: 1/50), phospho-Akt Ser473 (rabbit, 
#4060; WB: 1/4000; IC: 1/200), and phospho-Akt Thr308 
(rabbit, #9275; WB: 1/1000) were purchased from Cell 
Signaling, Danvers, MA, USA. Rabbit anti-GFP antibody 
(Sc-8334; WB: 1/4000) was obtained from Santa Cruz 
Biotechnology, Dallas, TX, USA, rabbit antiserum against 
Calnexin (ADI-SPA-860; WB: 1/4000) from Enzo Life 
Sciences, Farmingdale, NY, USA. Monoclonal antibody 
against GAPDH (CB1001; WB: 1/4000) was supplied by 
Calbiochem, Billerica, MA, USA, and antibodies against 
γ-adaptin (mouse, A36120 lot 1; IC: 1/1000) and anti-
GM130 (mouse, 610822; IC: 1/500) were obtained from 
BD Biosciences, San Jose, CA, USA. Goat anti-choline 
Fig. 1  Schematic of the targeted mutation 1a allele 
(Syap1tm1a(EUCOMM)Hmgu) of the mouse Syap1 gene (a, details in text), 
amino acid sequence of mouse Syap1 protein (b), and fusion protein 
(red amino acids) expressed in knock-out mouse (b, c). Syap1 exons 
1–3 encoding the red sequences in b are spliced to sequences encod-
ing a fragment of mouse engrailed-2 protein shown in c. Conserved 
amino acids of the BSD domain (underlined in b) are marked in blue
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acetyltransferase (AB144p; IC: 1/1000) and mouse anti-
NeuN (MAB377; IC 1/400) were ordered from Millipore, 
Darmstadt, Germany, and mouse monoclonal antibody 
against CalbindinD-28K was purchased from Sigma, St. 
Louis, Missouri, USA (mouse, C9848; IC: 1/1000). Guinea 
pig anti-vGlut1 (135304; IC: 1/2000) and mouse anti-
GFAP (173011; IC: 1/2000) were obtained from Synaptic 
Systems, Goettingen, Germany. Secondary antibodies, don-
key anti-rabbit Cy3 (711-165-152), donkey anti-mouse Cy5 
(715-175-150), donkey anti-chicken Alexa488 (703-545-
155), donkey anti-goat Alexa488 (705-545-147), goat anti-
rabbit peroxidase coupled (111-035-003; WB: 1/5000), 
and goat anti-mouse (115-035-003; WB: 1/5000) were 
provided by Jackson Laboratory, Farmington, CT, USA. 
Fluorophore-coupled secondary antibodies were from 
Jackson Laboratory (IC: 1/800), except goat anti-mouse 
IgG1-gamma chain Cy5-labeled antibody (IC: 1/500) was 
obtained from Abcam (ab136127). Horseradish peroxidase-
coupled goat anti-rat antibody was obtained from Rock-
land, Limerick, PA, USA (612-103-120; WB: 1/5000); 
Phalloidin Fluor546 (IC: 1/30) was supplied by Life 
Technologies Corporation Grand Island, NY, USA; and 
α-Bungarotoxin Alexa647 conjugate was purchased from 
Thermo Fisher Scientific, Erlangen, Germany (B-35450; 
IC: 1/500).
Immunohistochemistry
Adult wild-type or Syap1 knock-out littermate mice (age 
between 6 and 8 weeks) were euthanized by the applica-
tion of CO2 for approximately 3 min. Animals were first 
perfused trans-cardially with phosphate-buffered saline 
(PBS) containing 0.4 % heparin to remove the blood from 
the arteries and veins. To fix the tissues, perfusion was per-
formed with 4 % paraformaldehyde in PBS (PFA). Brain 
and lumbar spinal cord were carefully dissected and post-
fixed for at least 2 h with 4 % PFA at 4 °C followed by 
three washing steps with PBS and stored at 4 °C in PBS. 
The tissues were embedded in 6 % agarose, and 30- to 
40-µm-thick vibratome sections were produced and stored 
in cryo-protection buffer (30 % ethylene glycol, 25 % glyc-
erol, 0.05 M phosphate buffer pH 7.4) at −20 °C until use. 
Prior to immunolabeling, the sections were transferred to a 
24-well dish and washed three times with PBS to remove 
cryo-protection buffer. Blocking and permeabilization was 
carried out in blocking buffer (0.3 % Triton X-100, 0.1 % 
Tween-20, 10 % donkey serum (Bio-Rad, USA, C06SBZ) 
in PBS) for 1 h at room temperature and 1 h at 37 °C. The 
sections were incubated in primary antibodies diluted in 
blocking buffer for 2 days at 4 °C on a shaker followed by 
three washes in washing buffer (0.3 % Tween-20, 0.1 % 
Triton X-100 in PBS) for 15 min each and incubated with 
secondary antibodies in blocking buffer for 2 h at room 
temperature. Three additional washing steps (45 min each) 
were performed prior to 4′,6-diamidine-2′-phenylindole 
dihydrochloride (DAPI, 0.4 µg/ml) staining. Sections 
were washed with PBS and embedded in FluorSaveTM 
(Millipore).
To investigate the distribution of Syap1 at neuromuscu-
lar synapses, the gastrocnemius muscles from adult Bl/6 
WT and Syap1 KO mice were dissected after perfusion. 
After 2 h post-fixation, single fibers were picked out and 
washed in 0.1 M glycine buffered with PBS. To visual-
ize postsynaptic structures, nicotinic acetylcholine recep-
tors were stained with α-bungarotoxin-Alexa-Fluor 647 
in PBS for 20 min at RT and the fibers were washed for 
20 min in PBS. Subsequently, the fibers were permeabi-
lized and blocked with 10 % donkey serum, 0.3 % Triton 
X-100 for 1 h. The presynaptic site of the neuromuscular 
end plate was labeled with anti-synaptophysin. Antibodies 
were diluted in blocking solution and incubated over night 
at 4 °C. Subsequently, the tissue was washed three times 
in PBS for 10 min each, before the appropriate second-
ary antibodies were added. Finally, the fibers were washed 
again three times with PBS and mounted on a glass slide.
Immunocytochemistry
For immunocytochemistry, cells cultured on 10-mm cover-
slips were washed once with pre-warmed PBS and subse-
quently fixed with 4 % PFA for 10 min at 37 °C. After fixa-
tion, the motoneurons were permeabilized with blocking 
buffer containing 0.1–0.3 % Triton X-100 and 10 % don-
key serum in PBS for 30 min at room temperature. Primary 
antibodies were diluted in blocking buffer and incubated 
over night at 4 °C. Cells were then washed 5 times for 
5 min each with washing buffer (0.1 % Triton X-100, 0.2 % 
Tween-20 in PBS) and incubated with secondary antibodies 
diluted in freshly prepared blocking buffer for 1 h at room 
temperature. Subsequently, the motoneurons were washed 
again twice for 5 min, followed by 10 min of DAPI (0.4 µg/
ml) staining. After three additional washes, the coverslips 
were washed again once with ddH2O and mounted on glass 
slides using FluorSaveTM (Millipore).
Lentivirus production for Syap1 knockdown 
and controls
pLL3.7 lentiviruses were produced as previously described 
(Subramanian et al. 2012), expressing either shRNA 
against Syap1 or a mismatch shRNA, both co-expressing a 
GFP reporter gene as internal infection control. The knock-
down vector for Syap1 and a mismatch shRNA (Selvaraj 
et al. 2012) were obtained by cloning a Syap1 (5′-TGA 
GAC AAT TCA ACA GCA GAT TCA AGA GAT CTG 
CTG TTG AAT TGT CTC TTT TTTC-3′) and a mismatch 
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shRNA sequence (5′-GAA AAA AGG TTA GAA ACT 
TAA AGT GTT CTC TTG AAA CAC TTT AAG TTT CTA 
ACC A-3′) into the pLL3.7 lentivirus. In general, infection 
levels above 90 % were achieved.
Embryonic mouse motoneuron culture
Motoneurons were isolated and enriched from lumbar spi-
nal cords from E13.5 mouse embryos as described (Wiese 
et al. 2010). The lumbar spinal cord was dissected and 
ensheathing meninges removed. The tissue was trypsinized 
(0.1 %) for 15 min at 37 °C and subsequently gently tritu-
rated until a uniform cell suspension was obtained. Moto-
neurons were enriched by p75-antibody panning [5 ng/
ml to precoat Nunclon Δ surface culture dishes (Sigma); 
p75-antibody clone MLR2 was originally generated and 
provided by the R. Rush Lab, Flinders University, Ade-
laide, Australia; (Rogers et al. 2006)]. By this method, 
a motoneuron culture of 90 % purity is achieved (Wiese 
et al. 1999). Cells were plated on poly-DL-ornithine hyd-
robromide (PORN, Sigma P8638) and laminin-111 (Inv-
itrogen, Thermo Fisher Scientific, Waltham, MA USA 
23017-015)-coated 10-mm coverslips in CELLSTARtissue 
culture dishes (Greiner Bio-One GmbH, Frickenhausen, 
Germany) or on 24-well Nunclon Δ surface culture dishes, 
depending on the experiment. The motoneurons were 
grown in neurobasal medium, 500 µM GlutaMAX (Invit-
rogen), 2 % B27 supplement (Invitrogen), 2 % horse serum 
(Linaris, Dossenheim, Germany), and 5 ng/ml BDNF 
or 5 ng/ml CNTF. 50 % of the culture medium was first 
replaced at day 1 and then every second day. Appropri-
ate lentiviral infections were performed in a small vol-
ume prior to the plating of the cells. Infected motoneurons 
were detected by GFP reporter expression from lentiviral 
constructs.
Stimulation experiments
Motoneurons were cultured for 5 DIV in the presence of 
CNTF (5 ng/ml) and serum-starved overnight. The cells 
were then stimulated with 0.1 % BSA-coated BDNF 
(20 ng/ml) for the indicated time periods or treated with 
0.1 % BSA (unstimulated control), washed once with PBS, 
and directly extracted in Laemmli buffer. Subsequently, 
equal volumes were analyzed by Western blot.
For immunocytochemical analysis of the pAktSer473/Akt 
ratio in stimulated cells, motoneurons were grown for 5 
DIV, starved for 6–7 h in Neurobasal medium containing 
B27 (insulin free; Invitrogen), and pulsed for 5 min with 
BDNF (20 ng/ml). Unstimulated cells were cultured for 5 
DIV in the presence of 5 ng/ml BDNF. Subsequently, the 
cells were immediately washed with PBS, fixed with 4 % 
PFA, and stained against pAktSer473, Akt, and GFP. The 
images were taken at an Olympus Fluo View FV1000 con-
focal microscope and quantified by using the average inten-
sity signals of the z-stacks. Technical background values 
(no tissue) were subtracted from the mean intensity values.
Western blot analysis
Western blots were performed following standard proce-
dures. Motoneurons were directly lysed in Laemmli buffer. 
Tissues dissected from adult mice (killed by cervical dis-
location) were lysed in RIPA buffer followed by Bradford 
protein assay. Laemmli buffer was added to the samples to 
adjust for a final concentration of 2× and boiled for 10 min 
at 99 °C. 20 µg of protein was loaded. Incubation of the 
blots with primary antibodies was performed overnight at 
4 °C in a 5 % milk (for phosphoprotein detection of 5 % 
BSA) solution followed by at least three washing steps. 
Secondary antibodies were added for 1 h at room temper-
ature; subsequently, the blots were washed at least three 
times and developed with either ECL or ECL Advance sys-
tems (GE healthcare. Munich, Germany). ImageJ was used 
for densitometric quantification of specific signals, and 
unspecific background was subtracted.
Survival assay, axon length measurements
The survival of motoneurons was quantified by plating 
1000 cells per well (four-well dish). On day one, the num-
ber of motoneurons in a marked area in the center of the 
well containing about 20–100 cells was counted. After 7 
DIV, the counting was performed again and the survival 
rate was calculated. For axon length measurements, 1500–
2000 cells per coverslip were cultured and fixed after 7 DIV 
and stained for α-tubulin. At least 50 cells per experiment 
were examined under double-blinded conditions regarding 
genotype and cell treatment.
Microscopy
Imaging for axon length or mouse brain section overview 
was performed with a Keyence 0.43 microscope using 
a NIKON PlanAPO 20x or 2x objective, respectively. 
Axon length measurements were taken using ImageJ soft-
ware (Rasband, W. S., ImageJ, US National Institutes 
of Health, Bethesda, Maryland, USA, http://imagej.nih.
gov/ij/, 1997–2015). 12-bit images for Syap1 localiza-
tion in cultured motoneurons and mouse brain sections 
were taken using an Olympus Fluoview FV1000 confocal 
microscope with a FVD10 SPD spectral detector and diode 
lasers of 405, 473, 559, and 635 nm. The image x-, y-, and 
z-stacks were acquired with an Olympus UPLSAPO 10× 
(air), 20× (air), or 60× objective (oil, numerical aperture: 
1.35). For intensity measurements, average intensities were 
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determined from 12-bit raw images and were corrected for 
technical background (no tissue). Structured illumination 
microscopy was performed at a Zeiss ELYRA S.1 micro-
scope using a PLAN APOCHROMAT 63× objective (oil, 
numerical aperture 1.4) generating 16-bit images. Unless 
otherwise noted, motoneuron images show the maximum 
projection of z-stacks represented in RGB format (8-bit 
per color channel). Identical confocal imaging settings and 
adjustments of brightness and contrast were used to com-
pare anti-Syap1 immunoreactivity (IR) in cells under unin-
fected, mock-infected and sh-Syap1-infected conditions 
or in wild-type and knock-out tissue. Final processing of 
all images was performed with ImageJ and Photoshop 7.0 
(Adobe). Pixel intensity-based co-localization of antibody-
derived fluorescent signals was performed with an unbiased 
algorithmic method in two-color single-plane confocal 
images using the JACoP v2.0 plugin in ImageJ (Bolte and 
Cordelieres 2006). The values given represent Pearson’s 
correlation coefficient after Costes’ randomization (Costes 
et al. 2004) (mean ± SEM) for pixels, where two channels, 
representing corresponding immunoreactivity, are above a 
calculated intensity threshold at which pixels do not show 
any statistical correlation.
Statistical analysis
At least three independent experiments were performed 
for statistical analysis with the GraphPad Prism 4 soft-
ware. Unless indicated otherwise, data are expressed as 
mean ± standard error of the mean (SEM). In general, the 
analysis of variance (ANOVA) with Bonferroni post hoc 
test (if data were normally distributed) or for nonparamet-
ric statistics Kruskal–Wallis test with Dunn’s multiple com-
parison was applied.
Results
Initial phenotypic characterization of the Syap1 
gene‑trap mouse
Heterozygous X-chromosomal Syap1 gene-trap mice 
(Syap1+/tm1a) in C57BL/6N background were crossed 
to C57BL/6J mice in order to produce mutant males and 
females and to reduce non-C57BL/6J genetic background. 
Hemizygous Syap1tm1a F2 males were crossed to Syap1+/
tm1a heterozygote females to obtain homozygous Syap1tm1a/
tm1a (Syap1-/-) female animals. Frequencies of offspring 
genotypes so far were compatible with an assumption of 
reduced viability of females homozygous for the Syap1tm1a 
allele (data Table 1). No obvious differences in size or mor-
phology between homozygous, hemizygous, heterozygous 
mutant, and wild-type littermates of the same sex were 
noted. The weights of mutant and wild-type males were 
not significantly different (weight ratio mutant/wild-type 
0.996 ± 0.025, 4 age groups, 12 mutant and 12 wild-type 
animals, P = 0.56). Since the tma1 insertion allele does 
not delete Syap1 coding sequences (Fig. 1), we determined 
whether any residual intact Syap1 transcript or protein 
was generated by exon-3 to exon-4 splicing (ignoring the 
closer En-2 splice acceptor site (SA) of the tm1a insertion). 
qRT-PCR of cDNA isolated from wild-type and Syap1-/- 
mutant brain with primers connecting exon-3 to exon-4 
showed a reduction in the mutant of transcripts expressing 
these exons to 5.68 ± 0.54 % of wild-type levels (n = 6 
independent experiments) (Fig. 2a). Transcripts contain-
ing exon-8 and exon-9 were reduced in the mutant to 
14.8 ± 2.9 % (n = 3). Using an antiserum against Syap1 
(characterized in Online Resource 1), we observed in West-
ern blots of tissue lysates from wild type a clear Syap1 
signal for all brain areas, for spinal cord, for sciatic nerve, 
but also for non-neuronal tissues such as diaphragm (Fig. 
S2a) and liver at the expected apparent relative molecular 
weight of 56 kDa (Fig. 2b). Corresponding tissue lysates 
from Syap1-/- mutant mice showed no Syap1 signal. When 
more protein was loaded and exposure was extended, back-
ground signals and Syap1 degradation products showed up 
in the wild-type lane, but no Syap1 signal was detected in 
tissues from mutant mice (Fig. 2c). Under these conditions, 
the wild-type signal of hippocampal homogenate was still 
detectable when a 1:100 dilution of the lysates was loaded 
(Fig. S2b). These results demonstrate that Syap1 is abun-
dant in nervous tissue, but it is not a nervous system-spe-
cific protein. In view of the observation that in the Syap1 
mutants intact Syap1 protein is absent (or reduced to less 
than 1 % of its normal level) and that in the Syap1–En2 
fusion protein more than 80 % of the Syap1 primary struc-
ture is missing [including the functionally relevant BSD 
Table 1  Genotype distributions 
of offspring (F1) of the 
indicated parental (P) crosses 
for the first three generations of 
Syap1tm1a mutant mice
Distributions of progeny of wild-type males and heterozygotes are compatible with Mendelian inherit-
ance (P = 0.30), and progeny of mutant males and heterozygotes could point to a deleterious effect of the 
Syap1tm1a allele (P < 0.01, Chi–square test)
P Y/+ × +/− Y/− × +/−
F1 Y/+ Y/− +/+ +/− Y/+ Y/− +/− −/−
16 23 28 19 9 3 15 4
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domain (Doerks et al. 2002; Yao et al. 2013)] (Fig. 1), we 
conclude that the Syap1tm1a allele may be regarded as a null 
allele on a functional level.
Syap1 distribution in the adult mouse brain
With the availability of Syap1 knock-out animals, it now is 
possible to reliably determine the distribution of Syap1 in 
wild-type tissues at the cellular and subcellular level. Since 
so far we have no information about the function of Syap1 
in mammalian nervous system, we here give an over-
view on Syap1 localization in various parts of the mouse 
brain and report in more detail the distribution in selected 
regions. Comparison of coronal sections of wild-type and 
Syap1 knock-out brains immuno-reacted with the Syap1 
antiserum reveals intense Syap1-specific immunofluores-
cence throughout the brain with regionally distinct distribu-
tion patterns (Fig. 3). Fluorescent signals observed in both 
wild-type and knock-out sections (e.g., individual cells in 
the hypothalamus, arrowheads in Fig. 3a, c; distinct fiber-
like structures in other brain areas, see below) are lacking 
in negative controls incubated without Syap1 antiserum 
(Fig. S3). This indicates the cross-reactivity of the antise-
rum with an unknown antigen and emphasizes the necessity 
of comparing wild-type and knock-out sections processed 
in parallel for specifically characterizing Syap1 distribution 
in the various brain areas, as done in the present study.
At low magnification, most brain areas display diffuse 
Syap1-specific immunolabeling (Fig. 3a, e), and compari-
son with neuronal localization patterns visualized by DAPI 
nuclear counterstaining (Fig. 3b, f) indicates a preferential 
localization of the protein in gray matter neuropil. This 
is obvious in cortical regions and hippocampus, and is 
especially prominent in the cerebellum, where the molecu-
lar layer displays particularly intense diffuse fluorescence 
while the granular layer and the cerebellar medulla are sig-
nificantly less strongly labeled (Fig. 3e, f, see below). In the 
olfactory bulb, Syap1 immunolabeling is strongest in the 
olfactory nerve layer and olfactory glomeruli (Fig. 4a, left 
column), which contain the glutamatergic terminals of the 
olfactory nerve axons and are surrounded and delineated 
by tyrosine hydroxylase (TH) immunoreactive dopaminer-
gic periglomerular cells and their processes extending into 
the glomeruli (Fig. 4a, middle column). While there is light 
Syap1 immunoreactivity in the mitral layer (arrowheads in 
Fig. 4a), there is no conspicuous staining observed in the 
perikarya of dopaminergic periglomerular cells (arrows in 
Fig. 4c).
In the thalamus, a region of enhanced Syap1 immuno-
labeling is observed (marked by an asterisk in Fig. 3a, 
compared with knockout in b). At higher magnification 
(Fig. 5a, c), it becomes apparent that this is caused by peri-
nuclear accumulations of Syap1-immunoreactive material 
in numerous neurons (identified by their typical nuclei in 
DAPI staining, Fig. 5a′, c′, or by double staining with anti-
NeuN antibodies, a neuron-specific marker (Fig. S4b), in 
close association with immunofluorescence for GM130, a 
marker for the cis/medial-Golgi apparatus (Nakamura et al. 
1995) in dual immunolabelings (Fig. 5a, a′). In astrocytes 
and presumably other non-neuronal cells displaying com-
paratively small and heterochromatin-rich nuclei in DAPI 
stainings, accumulation of Syap1-immunoreactivity near 
the Golgi apparatus is lacking (arrow in Figs. 5a′, S4a, b). 
Also, the fact that apparently not all neuronal nuclei are 
surrounded by Syap1-immunoreactivity (Fig. 5c′) indi-
cates that Syap1 expression is under cell-(sub)type-specific 
Fig. 2  Verification of Syap1 knockout and demonstration of Syap1 
protein expression in different tissues. a qRT-PCR with mRNA from 
mouse cortex and primers connecting Syap1 exon-3 and exon-4 dem-
onstrates that intact transcript levels are reduced in the Syap1tm1a 
mutant (curves 3, 4) by a factor of ~30 compared to wild type (curves 
1, 2). Curve 5 indicates background (no reverse transcriptase). b 
Lysates of the indicated tissues analyzed by Western blots show com-
parable levels of Syap1 protein expression in all tested brain regions 
of wild‑type mice. However, the protein is also detected in non-neural 
tissues such as liver (left half of blot). No Syap1 signals are obtained 
for tissues from Syaptm1a mutant mice (right half of blot). c No trace 
of the Syap1 protein is detected by Western blots in lysates of hip-
pocampus from Syaptm1a mutant (lane 2) even after increased pro-
tein loading and extended exposure. The two weak upper bands are 
unspecific, and the weak lower bands presumably represent Syap1 
degradation products. Top parts of blots in b and c: Calnexin signals 
as loading controls
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Fig. 3  Sections of wild type 
(a, b, e, f) and Syap1 knock-
out (c, d, g, h) brains stained 
with Syap1 antiserum (left) 
and DAPI (right). In coronal 
sections (a, c), diffuse Syap1-
specific immunolabeling is 
found throughout all parts of the 
brain, preferentially localized 
in the gray matter neuropil. 
Arrowheads point to hypotha-
lamic cells that unspecifically 
cross-react with the Syap1 
antiserum as they are detected 
both in wild-type and knock-
out sections but not in controls 
without primary antibody (see 
Fig. S3). The asterisk indicates 
a thalamic region containing 
numerous cells with strong 
perinuclear Syap1-specific 
immunofluorescence labeling 
(enlarged in Fig. 5). Sagittal 
sections reveal particularly 
intense immunofluorescence 
for Syap1 in the molecular 
layer of the cerebellar cortex (e, 
g). Scale bars 1 mm (upper), 
200 µm (lower) panels
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Fig. 4  In the main olfactory bulb, intense Syap1-specific immunore-
activity is observed in olfactory nerve layer (asterisk) and glomeruli 
(x) of wild-type sections (a, c). Less intense Syap1 signals are found 
in the mitral layer (arrowheads in a). The Syap1 antiserum weakly 
cross-reacts with an unknown antigen in knock-out sections (b, d). 
Dual immunolabeling with anti-Syap1 antiserum (left) and anti-TH 
(middle) reveals Syap1 accumulation in glomerular neuropil. Nuclei 
are stained by DAPI [blue in the overlay (right)]. Scale bars 200 µm 
(upper half), 50 µm (lower half)
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Fig. 5  Syap1 distribution in the thalamus. a Enhanced staining of 
anti-Syap1 (left) in a certain region of the wild-type thalamus (indi-
cated in Fig. 3a by an asterisk) is by double staining with the Golgi 
marker GM130 (middle) identified as perinuclear accumulation of 
Syap1-specific immunofluorescence near the Golgi apparatus. Yellow 
color in the enlargement in a′ indicates overlap of Syap1 and GM130, 
and arrow points to GM130-immunoreactive Golgi apparatus in 
a presumably non-neuronal cell (as indicated by a densely DAPI-
stained nucleus) lacking Syap1 immunolabeling. c This perinuclear 
accumulation of Syap1-specific immunofluorescence is confined to 
a subpopulation also of neurons as revealed in the enlargement (c′) 
by nuclei labeled with DAPI (blue) devoid of Syap1-specific immu-
nofluorescence (red). Comparison with knock-out sections in b and 
d (left and middle panels) shows fine fluorescent fiber-like structures 
labeled due to unspecific cross-reaction of the anti-Syap1 antiserum. 
Scale bars 25 µm (a, c); 5 µm (a′, c′)
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Fig. 6  Syap1 distribution in the hippocampus. a In wild-type sec-
tions, Syap1-specific immunofluorescence is present in general neu-
ropil, high levels of Syap1-labeling are observed in CA2 perikarya 
(large arrowheads), and Syap1 immunoreactivity is also detectable to 
a weaker extent in CA1 or CA3 perikarya (small arrowheads), com-
pared with knock-out sections (b, d). The infra- and suprapyramidal 
mossy fiber pathways arising from dentate gyrus granule cells show 
intense Syap1-specific immunoreactivity (arrows). Syap1 is also 
found in the stratum lucidum. (c, d) The enlargement of the CA2 
region double stained with anti-Syap1 and GM130 demonstrates the 
association of perinuclear Syap1 with the Golgi apparatus of these 
cells. Hi, hilus; SG, stratum granulosum; SL, stratum lucidum; SLM, 
stratum lacunosum-moleculare; SM, stratum moleculare; SO, stra-
tum oriens; SP, stratum pyramidale; SR, stratum radiatum. Scale bars 
200 µm (a, b), 50 µm (c, d), 10 µm (inset in c)
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control. This becomes even more obvious in the hippocam-
pus. Here, we find low levels of Syap1-specific immu-
nofluorescence in the pyramidal layer of CA1 and CA3 
(small arrowheads in Fig. 6a), but high concentrations in 
practically all perikarya of the CA2 pyramidal layer (large 
arrowheads in Fig. 6a, at higher magnification in c). Again, 
association with GM130-immunoreactivity is notable in 
CA2 neuronal perikarya (Fig. 6c, inset). This observa-
tion induced us to ask whether the structure of the Golgi 
apparatus was noticeably altered when Syap1 protein was 
missing. We therefore compared GM130 staining in wild-
type and Syap1 knock-out brain sections at higher magni-
fication. No qualitative effect of Syap1 knockout on Golgi 
structure as revealed by light microscopical GM130 stain-
ing was noted (Fig. S6). Medium intense, diffuse Syap1-
immunoreactivity is observed in the dentate gyrus stratum 
moleculare and in the CA stratum lacunosum-moleculare. 
In CA1, the strata oriens and radiatum display medium 
high and low immunoreactivity levels, respectively. While 
dentate gyrus granule cells display scarce perinuclear labe-
ling, the hilus contains strong punctate Syap1-immunore-
activity (Figs. 6a, S5a) which extends into the CA3 region, 
forming two bands of particularly intense fluorescence 
adjacent to CA3 somata (arrows in Figs. 6a, S5b) cor-
responding to the supra- and infrapyramidal mossy fiber 
pathways, the suprapyramidal band extending throughout 
the stratum lucidum of CA3 into CA2 (Fig. 6a). In dual 
immunolabelings, partial co-localization of Syap1 with the 
vesicular glutamate transporter vGlut1 is observed in the 
mossy fiber pathway (Fig. S5a, b), indicating the presence 
of the protein in the particularly large glutamatergic mossy 
fiber boutons but also in additional non-vGlut1 immunore-
active elements.
In the cerebellum, pronounced Syap1 staining is 
observed in the perinuclear cytoplasm of Purkinje cells 
(Fig. 7a, c, e, asterisks), particularly concentrated close 
to the emerging dendritic tree, again associated with the 
Golgi complex identified by GM130 co-labeling (Fig. 7c′). 
In addition, Syap1 immunoreactive puncta are distributed 
throughout the Purkinje cell dendrites (arrowheads in 
Fig. 7e) and in the molecular layer neuropil between the 
larger dendrites where numerous glutamatergic synapses 
are formed by parallel and climbing fibers. Co-staining 
for vGlut1 reveals partial overlap of the immunoreaction 
signals (Fig. 7a, c, e, compares with knockout in b, d, f). 
In the granular layer, medium levels of Syap1 immuno-
reactivity are observed, again partially overlapping with 
vGlut1 immunoreactivity identifying the large mossy fiber 
boutons of cerebellar glomeruli, but with signals also in 
non-vGlut1-reactive puncta (Fig. 7c, gray square enlarged 
in Fig. S5c). In the spinal cord, some overlap of Syap1-
specific staining with choline acetyl transferase (ChAT) 
immunoreactivity in motoneuron somata is seen (Fig. 8a, 
c compares with knockout in b), but cholinergic synaptic 
boutons (arrowheads in c) contain little or no Syap1. Again, 
conspicuous association of the Syap1 signal with GM130 
immunoreactivity in motoneuron cell bodies is obvious 
(arrows in Fig. 8d). These latter findings induced us to 
investigate the distribution and possible functional aspects 
of Syap1 in cultured motoneurons. However, the choliner-
gic synapses at neuromuscular junctions and surrounding 
muscle tissue display only low levels of Syap1-specific 
immunofluorescence (Fig. 9).
Subcellular localization of Syap1 in isolated 
motoneurons
Motoneurons were isolated and enriched from E13.5 
mouse embryos as described in “Methods” section. Cells 
from wild-type and knock-out embryos were cultured for 
5 days, PFA-fixed and stained against Syap1 and acety-
lated tubulin, and counterstained with DAPI. In addition, 
wild-type cells infected either with the Syap1 knock-down 
virus or with the mock virus were compared. Strong sig-
nals obtained by confocal immunofluorescence micros-
copy were seen with the Syap1 antiserum in wild-type 
cells (Fig. 10a, c, e, g, i, k), but no specific staining was 
obtained in Syap1-/- knock-out cells (Fig. 10b, d, f). Resid-
ual fluorescence represents cross-reactivity of the primary 
antiserum as determined by omission of first antibody (not 
shown). A robust depletion of Syap1 signal after lentivi-
ral Syap1 knockdown was likewise apparent (Fig. 10h, j, 
l) by comparison with mock-treated (not shown) or unin-
fected control cells (Fig. 10g, i, k). Syap1 immunofluores-
cence revealed a punctate staining pattern which could be 
observed in somata, dendrites, axons, and growth cones of 
the motoneurons and was strongly reduced in knock-out or 
knock-down cells. The nucleus showed no distinct Syap1 
signal. At higher magnification of the cell bodies, a strong 
perinuclear Syap1 signal was detected (Fig. 10c, i) which 
was clearly lacking in knock-out and knock-down neurons 
Fig. 7  Syap1 distribution in the cerebellum. Syap1-specific immuno-
fluorescence accumulations largely overlap with glutamatergic synap-
tic neuropil labeled by anti-vGlut1 staining which marks the vesicular 
glutamate transporter of glutamatergic synapses [compare wild-type 
(a, c, e) with knock-out sections (b, d, f)]. In enlargements (e, f) of 
the regions indicated by the white squares in c and d, the perinuclear 
accumulation of Syap1-specific immunofluorescence in Purkinje 
cells identified by calbindin double labeling (center column in a–c) is 
apparent (asterisks in e), but Syap1 is also detected in the large den-
drites of these cells extending into the molecular layer (arrowheads in 
e). Again, Syap1 immunofluorescence partially overlaps with signals 
for the Golgi marker GM130 (yellow in c′, rightmost image). In the 
granular layer (gray square in c), Syap1-specific immunofluorescence 
overlaps with glutamatergic synapses but is also present in the peri-
nuclear region of granule neurons and the local neuropil (enlarged in 
Fig. S5c). Blue nuclear DAPI. Scale bars 100 µm (a, b), 25 µm (c, d), 
10 µm (c′, e, f)
▸
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(Fig. 10d, j). In axonal growth cones, punctate Syap1 sig-
nals appeared densest in regions containing high levels of 
F-actin as identified by Phalloidin staining (Cooper 1987; 
Fig. 10e, k). Low levels of fluorescent signals throughout 
terminal axons in knock-out and knock-down neurons 
(Fig. 10f, l) confirmed the specificity of strong Syap1 sig-
nals in actin-rich growth cone regions.
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Fig. 8  Syap1 (a, c, d, left column) in spinal cord neuropil and cholin-
ergic cells (motoneurons) labeled by anti-ChAT antiserum (a–c, mid-
dle column). Compare wild-type section (a) with knock-out section 
(b). Cells in white box in a are shown enlarged in c and d. Cholin-
ergic synaptic boutons (arrowheads in c) display little or no Syap1-
specific immunofluorescence. Again, there is considerable overlap of 
Syap1 signals and GM130 staining (arrows in d). Blue nuclear DAPI. 
Scale bars 100 µm (a, b); 50 µm (c, d)
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Syap1 localizes in close proximity to the Golgi 
apparatus and the trans‑Golgi network
In order to further define the subcellular localization of 
Syap1 in the cultured motoneurons, co-staining with anti-
bodies against the cis/medial-Golgi apparatus marker 
GM130, and against γ-adaptin, a component of the adap-
tor protein complex 1 (AP1) particularly accumulated in 
the trans-Golgi network (Boehm and Bonifacino 2001), 
was performed (Fig. 11). Syap1 staining was found con-
centrated next to the nucleus in close proximity to the cis/
medial-Golgi label (Fig. 11c, maximum intensity projec-
tions; orange arrowheads point at co-occurrence of both 
signals, while white arrowheads mark Syap1-positive, 
GM130-negative spots). Analyses of confocal optical sec-
tions revealed an average Pearson’s correlation coefficient 
after Costes’ randomization (PCC) of 0.66 ± 0.01 (pooled 
data of N = 50 cells, 4 independent cultures), indicating 
a non-random correlation between both immunoreactive 
signals. Syap1 and γ-adaptin IR (Fig. 11d) showed a PCC 
of 0.72 ± 0.01 (pooled data of N = 35 cells, 5 independ-
ent cultures). Confocal microscopy thus indicates a pro-
nounced localization of Syap1 to the perinuclear Golgi 
apparatus, confirming observations in the brain sections. To 
examine the localization of Syap1 at even higher resolution, 
structured illumination microscopy (SIM) was performed. 
SIM is a super-resolution imaging approach using standard 
fluorescent probes as immunocytochemical tags and offers 
here an x–y-resolution in the range of 120 nm (see Scher-
melleh et al. 2010). SIM microscopy again showed a fine-
structured, punctate distribution of Syap1 with a strong 
accumulation in the perinuclear Golgi region and a punc-
tate staining throughout the cytoplasm. SIM optical sec-
tions reveal a close proximity to GM130 in the perinuclear 
area, but only a rare co-occurrence of both labels. Syap1 
immunoreactivity did not follow the typical cisternae-like 
label of the cis/medial-Golgi marker GM130 (Fig. 11e, g; 
orange arrowheads point to co-occurrence of both signals, 
while white arrowheads point to Syap1-positive, GM130-
negative labels). Similarly, SIM images reveal an even less 
frequent overlap of Syap1- and γ-adaptin IR (Fig. 11f, h; 
yellow arrowheads point to co-occurrence of both signals, 
while white arrowheads point to Syap1-positive, γ-adaptin-
negative labels).
Syap1 knockout does not affect survival or axonal 
elongation in cultured primary motoneurons
Primary motoneurons in culture require neurotrophic fac-
tors for survival and growth of axons and dendrites. Thus, 
the role of cell-autonomous factors and their effects on 
signaling pathways controlling axon elongation and growth 
cone differentiation can be analyzed using this system 
(Calof and Reichardt 1984; Forscher and Smith 1988; 
Fig. 9  Syap1 at neuromuscular junctions. By comparison with the 
distribution of synaptophysin (SYP) and α-bungarotoxin (α-BTX), 
low levels of Syap1-specific immunofluorescence are identified at 
neuromuscular junctions, but Syap1 signals are also observed extra-
synaptically in the muscle. Compare wild-type (a) with knock-out 
preparation (b). Scale bars 10 µm
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Arakawa et al. 1990; Sanes and Lichtman 1999; Sendtner 
et al. 2000). To study the function of Syap1, we therefore 
investigated the effect of Syap1 knockout on survival and 
axon growth of cultured embryonic motoneurons (Fig. 12). 
After 7 days in vitro (DIV), there was no difference in the 
survival rate of Syap1 knockout in comparison with wild-
type motoneurons (P > 0.3), whereas a significant reduc-
tion in viability was observed when wild-type or knock-
out neurons were cultured without the neurotrophic factor 
BDNF (P < 0.05) (Fig. 12a; without BDNF: wild-type: 
24.9 ± 1.9 % (17); Syap1 knockout: 29.4 ± 2.4 (7); with 
BDNF: wild-type: 64.6 ± 3.6 % (17); Syap1 knockout: 
64.5 ± 5.6 % (7); (in parentheses: numbers of independ-
ent cultures). The mean values for axon length (Fig. 12b) 
also did not differ significantly between the genotypes 
(axon length wild type: 660.5 ± 16.8 µm; Syap1 knockout: 
659.4 ± 19.3 µm; (n = 4 independent cultures; numbers 
of cells pooled per condition: wild type: N = 288, Syap1 
knockout: N = 237). These results indicate that Syap1 
does not play a major role in microtubule dynamics or 
other molecular mechanisms relevant for neurite outgrowth 
(Paglini et al. 1998; Sendtner et al. 2000; Rossoll et al. 
2003; Jablonka et al. 2007; Selvaraj et al. 2012).
Syap1 deficiency apparently does not affect total Akt 
phosphorylation in primary motoneurons
In adipocyte differentiation, Syap1 regulates growth factor-
induced Akt1 phosphorylation at Ser473, and Syap1 knock-
down by shRNA strongly reduces this phosphorylation 
(Yao et al. 2013). To investigate whether knockdown or 
knockout of Syap1 in motoneurons also causes reduced Akt 
phosphorylation, we stimulated primary motoneurons after 
5 DIV in the presence of CNTF (5 ng/ml) and serum, fol-
lowed by neurotrophic factor deprivation for variable times 
(see Methods), with BDNF (20 ng/ml) and tested the levels 
of Akt phosphorylation at Thr308 and Ser473 using phospho-
specific antisera. In order to determine Akt phosphorylation 
kinetics at Thr308 and Ser473, we first stimulated motoneu-
rons for increasing durations ranging from 2 s to 30 min. 
Maximal Akt phosphorylation was achieved after 2–5 min 
of stimulation for both sites (Thr308 and Ser473) (Fig. 13a, 
n = 3). Since localization data were identical for knock-
out and knock-down motoneurons (Fig. 10), and West-
ern blots confirmed almost complete Syap1 deficiency in 
knock-down neurons (Fig. 13c, d right panels), the effect of 
Syap1 deficiency on Akt phosphorylation was determined 
with knock-out neurons after 5 min of BDNF stimulation 
(Fig. 13b), whereas experiments after 2- and 5-min stimu-
lation (Figs. 13c, d, S8) and tests for subcompartimental 
differences in stimulation effects (Figs. 14, S9) were car-
ried out on knock-down neurons which could be generated 
in comparatively large quantities from motoneurons pooled 
from wild-type embryos. The Western blots of Fig. 13 
revealed no reduction in Akt phosphorylation at Thr308 or 
Ser473 upon Syap1 knockout or knockdown compared to 
the controls. For the quantitative evaluation, densitometric 
signal values were normalized to the stimulated uninfected 
controls. The results depicted in Fig. S8 show no signifi-
cant difference in Akt phosphorylation after Syap1 knock-
out (Fig. S8a, 5-min stimulation, values normalized to 
stimulated wild type; Thr308(left): unstimulated, wild type 
0.13 ± 0.06; unstimulated, knockout: 0.15 ± 0.06; stimu-
lated, knockout: 1.58 ± 0.06 (n = 3), Ser473 (right) unstim-
ulated, wild type 0.23 ± 0.06; unstimulated, knockout: 
0.24 ± 0.08; stimulated, knockout: 1.48 ± 0.29 (n = 3)) 
or knockdown (Fig. S8b, values normalized to uninfected 
stimulated pAkt/Akt ratio, 2-min stimulation; Thr308(left): 
unstimulated, uninfected: 0.12 ± 0.06; stimulated, sh-
Syap1-infected: 1.58 ± 0.16; stimulated, mock-infected: 
1.27 ± 0.26 (n = 3), Ser473 (right) unstimulated, uninfected: 
0.39 ± 0.05; stimulated, sh-Syap1-infected: 1.27 ± 0.13, 
stimulated, mock-infected: 1.08 ± 0.04 (n = 3)); Fig. S8c, 
5-min stimulation; Thr308 (left): unstimulated, uninfected: 
0.06 ± 0.03; stimulated, sh-Syap1-infected: 1.31 ± 0.15; 
stimulated, mock-infected: 0.92 ± 0.05 (n = 3); Ser473 
(right) unstimulated, uninfected: 0.23 ± 0.07; stimulated, 
sh-Syap1-infected: 1.72 ± 0.17; stimulated, mock-infected: 
1.54 ± 0.24 (n = 3)).
In contrast to fibroblasts or adipocytes, neurons are 
forming different cellular compartments such as soma, 
axon, and growth cones. Thus, Syap1 might mediate local 
changes in Akt phosphorylation in these compartments. 
Such local changes in Akt phosphorylation might escape 
detection when whole cells are lysed for Western blot anal-
ysis. In order to investigate whether neuronal Syap1 inhib-
its Akt phosphorylation specifically in cell bodies, axons, 
or growth cones, we used Akt- and pAktSer473-specific anti-
bodies on cultured motoneurons to immunocytochemically 
determine phosphorylation of Akt at Ser473 separately in 
these compartments under conditions of 5 days in culture, 
6- to 7-h starvation, and 5-min BDNF stimulation (20 ng/
ml) (Fig. 14). Quantification of immunocytochemical fluo-
rescence signals in Syap1 shRNA- or mock-treated primary 
Fig. 10  Localization of Syap1 protein in cultured primary moto-
neurons. a Representative images of primary motoneurons cultured 
for 5 days and stained against Syap1 and acetylated tubulin or co-
stained with phalloidin, as indicated. Syap1 knock-out cells (b, d, f) 
and shRNA–Syap1-treated cells (h, j, l) show a robust reduction in 
Syap1 immunoreactivity compared to wild-type (a, c, e) or uninfected 
(g, i, k) and sh-mismatch RNA (“mock”)-infected (not shown) con-
trols. Syap1 signals are observed in the dendrites, soma, axon, and 
distal part of the axon. The magnified images of the somata (c, i) 
reveal punctate Syap1 staining in the cytoplasm and dendrites with 
a prominent perinuclear accumulation. Syap1 signals are also present 
in growth cones (e, k). Blue nuclear DAPI staining. Scale bars a, b, g, 
h: 25 µm; c–f, i–l: 10 µm
◂
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Fig. 11  Syap1 accumulates close to the Golgi organelle. (a–d) Peri-
nuclear Syap1 immunoreactivity partially co-stains with the cis/
medial-Golgi marker GM130 (a, c) and with γ-adaptin, a component 
of the adapter protein complex 1 (b, d) (maximum intensity projec-
tions). Blue nuclear DAPI staining. (e–h) Super-resolution imaging 
by SIM of Syap1 and GM130 or γ-adaptin. Typical single optical sec-
tions are shown. (e, g) Syap1 and GM130 distribution, (f, h) Syap1 
and γ-adaptin distribution. Orange arrowheads point to co-occur-
rence of both labels, and white arrowheads indicate Syap1-positive, 
GM130- or γ-adaptin-negative signals. Scale bars a, b, e, f 10 µm; c, 
d 5 µm; g, h 2.5 µm
Fig. 12  Knockout of Syap1 does not modify survival or axonal out-
growth of primary motoneurons. a Quantification of the survival of 
primary motoneurons cultured for 7 DIV in the absence or presence 
of BDNF. Cells were counted on day 1 and again on day 7. There 
is no significant difference in the survival rate of motoneurons from 
Syap1 knockout (ko) compared to wild-type (WT) embryos [n = 17 
(WT) and 7 (ko) independent cultures]. Wild-type cells cultured 
without BDNF show highly reduced cell survival. b Axon length of 
primary motoneurons cultured for 7 DIV is not affected by Syap1 
knockout (n = 288 for WT and 237 for ko)
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motoneurons shows that the ratio of pAktSer473 to total Akt 
does not decrease after Syap1 knockdown, irrespective of 
whether signals from soma, distal axons, or axonal growth 
cones are analyzed (Fig. S9) (pAktSer473/Akt ratios nor-
malized to unstimulated mock-infected condition: soma: 
unstimulated sh-Syap1-infected: 0.92 ± 0.09; stimulated, 
mock-infected: 4.85 ± 1.07; stimulated, sh-Syap1-infected: 
4.46 ± 0.86; distal axon: unstimulated sh-Syap1-infected: 
0.90 ± 0.07; stimulated, mock-infected: 3.11 ± 0.51; 
stimulated sh-Syap1-infected: 3.28 ± 0.55; growth cone: 
Fig. 13  Syap1 knockdown or 
knockout does not significantly 
influence total Akt phospho-
rylation at Thr308 and Ser473 in 
primary motoneurons. a West-
ern blot of serum-starved cells 
stimulated with BDNF (20 ng/
ml) in a time series ranging 
from 2 s to 30 min. Maximum 
Akt Thr308 (left blot) and Ser473 
(right blot) phosphorylation is 
achieved after 2–5 min of neu-
rotrophin stimulation. b Western 
blots of motoneurons from 
wild-type and Syap1 knock-out 
embryos stimulated for 5 min 
with BDNF did not reveal a 
reduction in Akt phospho-
rylation at Thr308 (left blot) or 
Ser473 (right blot) due to Syap1 
knockout. Calnexin and pan-Akt 
served as loading controls while 
GFP levels indicate a posi-
tive infection of the cells. c, d 
Blots of Syap1 shRNA-infected 
motoneurons and uninfected 
and mock-infected controls 
stimulated for two (c) or five (d) 
minutes with BDNF. No differ-
ences in Akt phosphorylation 
at Thr308 (left blots) and Ser473 
(right blots) were observed after 
Syap1 knockdown compared to 
controls. The detection of Syap1 
(right blots) demonstrates the 
strong reduction in Syap1 pro-
tein levels by the knockdown. 
Quantification of the signals of 
these and similar blots is shown 
in Fig. S8
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unstimulated, sh-Syap1-infected: 0.86 ± 0.04; stimulated, 
mock-infected: 3.01 ± 0.60; stimulated, sh-Syap1-infected: 
3.25 ± 0.70, n = 5 experiments, total number of cells eval-
uated per condition: 78–93). Likewise, no significant effect 
of Syap1 knockdown on pAktSer473/Akt ratios normalized 
to mock controls is seen when motoneurons were cultured 
under standard conditions without starvation and stimu-
lation (Fig. S9b). These findings support the conclusion 
from the Western blots of cell lysates (Figs. 13c, d, S8) that 
Syap1 knockdown in motoneurons does not decrease Akt 
phosphorylation at Ser473 and demonstrates that there are 
apparently no compartment-specific effects regarding this 
phosphorylation in somata, axons, or growth cones.
Discussion
Syap1 and Sap47 represent a protein family of unknown 
molecular function in the brain, but since its gene has been 
conserved from C. elegans and Drosophila to mouse and 
human, it is expected to convey a selection advantage. With 
the aim to determine its cellular and systemic distribution 
and function in the nervous system of mammals, we have 
generated a knock-out mouse and show here that the tm1a 
mutation of the Syap1 gene (Fig. 1) eliminates detectible 
amounts of Syap1 protein. In the knock-out brain, 6 % 
(14 %) of wild-type levels of Syap1 transcripts containing 
exon-3 and exon-4 (exon-8 and exon-9) are observed, but 
Fig. 14  pAktSer473/Akt ratios are not altered in different compart-
ments of stimulated motoneurons. After 5 DIV in the presence of 
CNTF (5 ng/ml), the cells were serum as well as neurotrophic factor 
deprived for 6–7 h and stimulated for 5 min with BDNF (20 ng/ml), 
followed by fixation and staining against pAktSer473, Akt, and GFP. 
Compartment-specific quantification of the pAktSer473/Akt ratios is 
shown in Fig. S9. pAktSer473/Akt ratios strongly increase upon BDNF 
stimulation, but comparable pAktSer473/Akt values were achieved after 
Syap1 knockdown or mock treatment in all the tested compartments 
of the motoneurons. Scale bars Soma and axon: 10 µm; growth cone: 
5 µm
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no wild-type protein can be detected (Figs. 2, S2b). This 
discrepancy between transcript and protein level reductions 
in the mutant could perhaps be explained by competition 
for translation initiation of the short transcripts containing 
exon-1 to exon-3 and En-2-lacZ sequences with the resid-
ual intact Syap1 transcripts. The different amounts of tran-
scripts containing exon-3 and exon-4 compared to exon-8 
and exon-9 might be due to partial RNA degradation or 
independent transcription initiation between exon-4 and 
exon-8.
Syap1 is found in most tissues of the adult mouse 
including nervous system (Figs. 2b, S2a). In the mouse 
brain, Syap1 immunoreactivity is widely distributed. Rela-
tively high levels of Syap1 are found in neuropil regions 
with high numbers of glutamatergic terminals, such as the 
hippocampal mossy fiber pathway (Kohara et al. 2014) 
(Figs. 6, S5a, b) and the molecular layer of the cerebel-
lum (Figs. 7, S5c). Non-neural cells in the brain appear to 
contain only low amounts of Syap1 (Figs. 5, S4a, b). Also, 
the nerve layer of the olfactory bulb and the olfactory glo-
meruli, containing the axons and the glutamatergic termi-
nals of the olfactory sensory neurons, respectively (Ennis 
et al. 2006), are rich in Syap1 (Fig. 4). In the cortex, the 
distribution of Syap1 seems to be more homogeneous, 
although again patterns of higher levels can be recognized 
which do not match with patterns of high density of somata 
as revealed by nuclear DAPI staining and thus may repre-
sent synaptic accumulations (Figs. 3a, S3). The apparently 
neuron-subtype-specific selective perinuclear Syap1 locali-
zation (in most but not all neuronal somata in a subdomain 
of the thalamus; in CA2, and with lower abundance in CA1 
or CA3 hippocampal pyramidal cells) indicates that Syap1 
is not simply a housekeeping gene but must have a func-
tion specific for a given cell type. Syap1 is also found in 
perinuclear structures of cholinergic neurons in the spi-
nal cord, but it does not accumulate in cholinergic synap-
tic boutons on these cells (Fig. 8). Low concentrations of 
Syap1 are observed at the cholinergic neuromuscular junc-
tions, apparently both presynaptically and in muscle tissue 
(Fig. 9).
As tentative résumé of this initial characterization of the 
distribution of Syap1 in the mouse central nervous system, 
we propose that Syap1 is present in most neuropil regions 
with high concentrations in regions containing glutamater-
gic synaptic terminals where vGlut1 co-labeling suggests 
that it may well be presynaptically localized, but that it may 
also be present in postsynaptic structures (Figs. 7, S5c). 
Its conspicuous perinuclear accumulation near the Golgi 
complex appears to be prominent in specific neuronal cell 
types, among which are glutamatergic (e.g., CA2 pyrami-
dal cells), GABAergic (e.g., Purkinje cells), and choliner-
gic neurons (spinal cord motoneurons). However, the elimi-
nation of Syap1 from these cells does not obviously alter 
the fine structure of the Golgi complex as seen in confocal 
microscopy (Fig. S6). The association of Syap1 with the 
Golgi complex apparently is not limited to nervous system 
cells, as suggested by Syap1 and GM130 double labeling 
of human embryonic kidney cells (Fig. S7). The ultrastruc-
tural and molecular basis of this association and the role of 
Syap1 in the complex functions of the Golgi organelle now 
need to be determined.
In addition to describing the distribution of Syap1 in the 
mouse brain, we tested whether this protein could play a 
major role in early motoneuron differentiation and cell-
autonomous axon growth and growth cone development 
in cultured embryonic motoneurons. This was of particular 
interest in view of the importance of Syap1 for the differ-
entiation of adipocytes from murine embryonic stem cells 
(Yao et al. 2013). In isolated mouse primary motoneurons, 
Syap1 is concentrated in a perinuclear region but is also 
present in axonal compartments (Fig. 10). Syap1 is detected 
in the axonal shaft as well as in the filopodia of the growth 
cone (Fig. 10e, k). This again indicates that Syap1 could 
have a presynaptic function similar to what was shown for 
Sap47 in Drosophila (Reichmuth et al. 1995; Saumweber 
et al. 2011).
In the motoneuron soma, Syap1 was found in close 
proximity to the cis/medial-Golgi marker GM130 and a 
component of the AP1 complex. The AP1 complex is one 
of four distinct AP complexes (AP1–4) which are present 
in mammalian cells, and each is reported to be implicated 
in a different trafficking pathway (Kirchhausen 1999; Rob-
inson and Bonifacino 2001). Besides its involvement in the 
anterograde transport from the trans-Golgi network (TGN) 
to endosomes, the AP1 complex is also believed to have 
a role in the recycling from endosomes to the TGN (Ahle 
et al. 1988; Robinson 1990; Meyer et al. 2000, 2001). The 
spatial relation of Syap1 with the cis-Golgi and the AP1 
complex was investigated by super-resolution microscopy 
(Fig. 11e–h). We conclude that Syap1 apparently does not 
co-localize with either GM130 or AP1 as the overlap with 
Syap1 signals decreases in super-resolution microscopy 
compared to normal confocal imaging.
The assumption of a synaptic role of Syap1, as its name 
suggests, was mainly based on the characterization of the 
Drosophila Syap1 homologue Sap47 which is predomi-
nantly found in synaptic neuropil and associated with syn-
aptic vesicles in glutamatergic synaptic boutons of larval 
motoneurons. The fact that in Drosophila larvae the Sap47 
gene is required for normal synaptic plasticity and asso-
ciative learning/memory (Saumweber et al. 2011) supports 
this assumption. However, developmental expression data 
for Drosophila (flybase, (St Pierre et al. 2014)) indicate that 
Sap47 transcription is already observed in the early embryo 
and thus is not linked to synaptogenesis, suggesting a more 
general cellular function. The prominent localization of 
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Syap1 in perinuclear Golgi-associated structures and in 
regions rich in glutamatergic synaptic terminals described 
here is consistent with both a synaptic and a more general 
cellular function also in mammals.
For adipocytes, it has been shown that Syap1 promotes 
mTORC2-mediated phosphorylation of Akt1 at Ser473 upon 
growth factor stimulation, and that this Syap1–Akt1 interac-
tion is critical for in vitro differentiation of these cells (Yao 
et al. 2013). In neurons, activation of Akt can be induced by 
neurotrophins such as BDNF (Huang and Reichardt 2003). 
Akt is phosphorylated at various amino acids. The protein 
is constitutively phosphorylated at a highly conserved site 
(Thr450) in the turn motive directly after translation, facilitat-
ing its folding and stability (Facchinetti et al. 2008). Akt is 
then fully activated by a dual phosphorylation at Thr308 and 
Ser473 (Alessi et al. 1996; Anderson et al. 1998; Sarbassov 
et al. 2005; Jacinto et al. 2006). In the mammalian nervous 
system, all three Akt genes are expressed. Phenotypes of sin-
gle and double knock-out mice suggest that the functions of 
the three isoforms are only partially redundant (Diez et al. 
2012; Cohen et al. 2011; Hers et al. 2011). The three proteins 
are so similar that the phospho-specific antibodies used in 
this study detect all three isoforms. Akt3 has been shown to 
be of particular importance in the nervous system (Tschopp 
et al. 2005; Easton et al. 2005). Thus, we cannot exclude that 
a possible Akt1 hypophosphorylation in motoneurons might 
be masked, e.g., by Akt3 hyperphosphorylation. The lack of 
changes in growth factor-induced Akt phosphorylation upon 
Syap1 knockout or knockdown in NSC cells (not shown) or in 
BDNF-stimulated or BDNF-unstimulated primary motoneu-
rons (Fig. 13b–d) does not support the hypothesis of a func-
tionally important Syap1–Akt interaction in these cells. Our 
experiments show that the knockdown of Syap1 (Fig. 13c, 
d, quantified in Fig. S1e) or its knockout (Fig. 2) apparently 
does not induce alterations in total Akt phosphorylation, 
neither in Western blots of homogenized motoneurons nor 
in immunocytochemical analysis of soma, axon, or growth 
cone, irrespective of the stimulation regime (Figs. 13, 14, S8, 
S9). We therefore propose that Syap1 may be involved in dif-
ferent molecular functions depending on cell type and per-
haps developmental state, and we speculate that Syap1 func-
tion in motoneurons is either independent of the Akt signaling 
pathway or isoform-specific mechanisms in the nervous sys-
tem operate to keep total Akt phosphorylation constant.
Altogether, considering the association of Syap1 with 
the Golgi complex shown here and the proximity of Sap47 
to glutamatergic synaptic vesicles in Drosophila, our data 
are compatible with a hypothesis that in the nervous system 
Syap1/Sap47 could be involved in vesicular trafficking in 
a large subpopulation of cell somata and in certain types 
of synaptic terminals. The function of this protein family, 
however, appears rather subtle as indicated by the viability 
of the knock-out flies and mice and the fact that in cultured 
mouse motoneurons no effects of Syap1 knockout on sur-
vival or axon outgrowth could be detected (Fig. 12). The 
characterization of the behavioral phenotype of the Syap1 
knock-out mouse is therefore eagerly awaited.
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